Genelux | Investor Presentation Deck | 37 slides · page 37 of 37
The slide uses clinical study data (VIRO-15, NCT01443260) to validate the mechanism of action.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 2/2 chart 2/2 image 2/2 title 1/1
Components 7
primary primary bar-stacked line photo photo headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.